Effectiveness of Kupferberg Classification-Based Treatment Protocol in Post Operative Management of Allergic Fungal Rhinosinusitis
Keywords:
Kupferberg, Treatment Protocol Post Operative Management CAD/CAM, Allergic Fungal RhinosinusitisAbstract
Background: Allergic fungal rhinosinusitis (AFRS) is a chronic condition managed surgically with functional endoscopic sinus surgery (FESS), but effective postoperative care is essential to prevent recurrence. This study evaluates the effectiveness of Kupferberg classification-based management in AFRS postoperative care.
Methods: A total of 65 AFRS patients underwent FESS with polypectomy, followed by a Kupferberg classification-guided steroid regimen. Patients were assessed at POD#5, POD#20, and monthly up to 6 months for symptom improvement and recurrence rates.
Results: Early improvement was seen at POD 5 and POD 20 (mean scores: 0.47, 0.48), but recurrence reached 50.8% by POD 6th month, correlating with poor compliance and inadequate maintenance therapy.
Conclusion: The Kupferberg classification-based protocol aids early symptom control but is insufficient in preventing long-term recurrence. Enhancing adherence strategies through extended steroid tapering and telemedicine follow-ups may improve outcomes.
Downloads
Metrics
References
. Marple, B. F. (2006). Allergic fungal rhinosinusitis: A review of clinical manifestations and current treatment strategies. Medical Mycology, 44(Supplement_1), S277–S284. https://doi.org/10.1080/13693780600778650
Kupferberg, S. B., Bent, J. P., & Kuhn, F. A. (1997). Prognosis for allergic fungal sinusitis. Otolaryngology–Head and Neck Surgery, 117(1), 35–41. https://doi.org/10.1016/S0194-5998(97)70210-0
Philpott, C. M., & Javer, A. R. (2011). Allergic fungal rhinosinusitis: A new staging system. Rhinology, 49(2), 217–222. https://doi.org/10.4193/Rhino10.121
Fokkens, W. J., Lund, V. J., Hopkins, C., et al. (2020). Executive summary of EPOS 2020 including integrated care pathways. Rhinology, 58(2), 82–111. https://doi.org/10.4193/Rhin20.601
Schubert, M. S., & Goetz, D. W. (2006). Evaluation and treatment of allergic fungal sinusitis. I. Demographics and diagnosis. Journal of Allergy and Clinical Immunology, 102(3), 387–394. https://doi.org/10.1016/S0091-6749(98)70128-6
Philpott et al. (2011): Philpott CM, Javer AR. Allergic fungal rhinosinusitis—a new staging system. Rhinology. 2011;49(3):318-323.
Chan et al. (2008): Chan KO, Genoway KA, Javer AR. Effectiveness of itraconazole in the management of refractory allergic fungal rhinosinusitis. J Otolaryngol Head Neck Surg. 2008;37(6):870-874.
Verma et al. (2017): Verma RK, Patro SK, Francis AA, Panda NK, Chakrabarti A, Singh P. Role of pre-operative versus post-operative itraconazole in allergic fungal rhinosinusitis. Med Mycol. 2017;55(6):614-623.
Angrish, P., & Shah, S. (2024). Itraconazole in medical management of patients with allergic fungal rhinosinusitis (AFRS). Indian Journal of Otolaryngology and Head & Neck Surgery, 76(1), 123-130.
Seiberling, K., & Wormald, P. J. (2009). The role of itraconazole in recalcitrant fungal sinusitis. American Journal of Rhinology & Allergy, 23(3), 303-306.
Khalil et al. (2011): Khalil Y, Tharwat A, Abdou AG, Essa E, Elsawy AH, Essawy AH, et al. The role of antifungal therapy in the prevention of recurrent allergic fungal rhinosinusitis after functional endoscopic sinus surgery: a randomized, controlled study. Ear Nose Throat J. 2011;90(8):E1-7.
Hashemi, S. M., & Majidi, M. R. (2021). The effect of preoperative itraconazole on the long-term outcomes of functional endoscopic sinus surgery in patients with allergic fungal rhinosinusitis. European Archives of Oto-Rhino-Laryngology, 278(5), 1537-1543.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.